Inhibition of CD40L with Frexalimab in Multiple Sclerosis
2024 · New England Journal of Medicine · 73 citations
https://doi.org/10.1056/nejmoa2309439
Y
Yang Mao‐Draayer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
4.1K
Citations
31
h-index
57
i10-index
Yang Mao‐Draayer is an academic researcher from University of Michigan–Ann Arbor. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Immunotherapy and Immune Responses. The author has an h-index of 31, co-authored 125 publications.
ORCID: 0000-0001-6248-3480Papers by this author
worksSymptomatic and restorative therapies in neuromyelitis optica spectrum disorders
2021 · Journal of Neurology · 30 citations
https://doi.org/10.1007/s00415-021-10783-4
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL
2022 · Multiple Sclerosis and Related Disorders · 13 citations
https://doi.org/10.1016/j.msard.2022.103922
A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods
2020 · BMC Urology · 11 citations
https://doi.org/10.1186/s12894-020-00629-y
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells
2024 · Cancer Immunology Immunotherapy · 9 citations
https://doi.org/10.1007/s00262-023-03578-1
Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the <scp>CROCTINO</scp> Cohort
2025 · European Journal of Neurology · 7 citations
https://doi.org/10.1111/ene.70214
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat